Lenalid 5mg Cap 30s
MRP: ₹4,386.00
Packaging
1 CAP
Composition
Lenalidomide 5mg
Company
Natco Pharma
MRP: ₹4,386.00
Packaging
1 CAP
Composition
Lenalidomide 5mg
Company
Natco Pharma
| Medicine | Company | Price | You Save |
|---|---|---|---|
| Lenangio 5mg Capsule 10s | Dr. Reddy | ₹632.00 | Save ₹3,754.00 |
| Lenmid 5 mg Capsule 10s | CIPLA | ₹1,000.00 | Save ₹3,386.00 |
| Lenzest 5mg Capsule 10s | Sun Pharma | ₹1,443.60 | Save ₹2,942.40 |
HTN, diarrhoea, upper respiratory tract infections, thrombocytopenia, leukopenia, pancytopenia, agranulocytosis, headache, alopecia, dry skin, eczema, erythema multiforme, hypokalaemia, weight loss, asthenia, anxiety, paraesthesia, synovitis, joint disorder, peripheral neuropathy, mild hyperlipidaemia, interstitial lung disease, vasculitis. Potentially Fatal: Hepatotoxicity, sepsis, Stevens-Johnson syndrome, toxic epidermal necrolysis, pancreatitis.
Cholestyramine and activated charcoal may decrease plasma concentration of active metabolite. Concurrent use of methotrexate and other hepatotoxic drugs may increase the risk of hepatotoxicity. Rifampicin increases serum levels of the active metabolite. Potentially Fatal: May enhance the adverse effects of live vaccines.
Hepatic impairment, moderate and severe renal impairment, compromised immune function including bone marrow dysplasia or severe uncontrolled infection, severe hypoproteinaemia; concurrent vaccination w/ live vaccines. Pregnancy and lactation.
Leflunomide is an immunomodulating agent and DMARD. It inhibits pyrimidine synthesis by inhibiting dihydroorotate dehydrogenase enzyme activity resulting in antiproliferative and anti-inflammatory effects. Absorption: Bioavailability: Approx 82-95%. Time to peak plasma concentration (active metabolite): 6-12 hr. Distribution: Volume of distribution: 0.13 L/kg. Plasma protein binding (active metabolite): 99% (mainly albumin). Metabolism: Rapidly converted to active metabolite A77 1726 in GI mucosa and the liver. Excretion: Via urine (approx 43% as glucuronides) and faeces (approx 48%). Elimination half-life (active metabolite): Approx 14-18 days.
Mild renal impairment. Patient w/ history of TB due to the possibility of reactivation of the infection. Monitoring Parameters Monitor BP and liver enzyme values prior to initiation and periodically during therapy.
Take orally with food and water, as directed by your physician.
Keep in a cool, dry place away from sunlight and moisture.
This content is for educational purposes only. Please consult your doctor before use.
| Brand Name | Form | Price |
|---|---|---|
| Aclocta 100mg Tablet 10s | TAB | ₹19.89 |
| Afanat 20 Tablet 28s | TAB | ₹3,100.00 |
| Albenat 200mg Suspension 10ml | SUSPENSION | ₹18.00 |
| Alphalan 2mg Tab 25s | TAB | ₹129.60 |
| Alphalan 5mg Tab 25s | TAB | ₹5,357.00 |
| Aminat 100mg Injection 2ml | INJECTION | ₹16.43 |
| Aminat 250mg Injection 2ml | INJECTION | ₹42.00 |
| Aminat 500mg Injection 2ml | INJECTION | ₹63.81 |
| Amoxinat 250mg Capsule 15s | CAP | ₹54.90 |
| Amoxinat 500mg Capsule 15s | CAP | ₹97.50 |
| Anaquin 250mg Tablet 10s | TAB | ₹5.60 |
| Anastronat 1mg Tablet 30s | TAB | ₹1,200.00 |
| Apigat 2.5 Tablet 30s | TAB | ₹720.00 |
| Apigat 5mg Tablet 30s | TAB | ₹855.00 |
| Arganat 250mg Injection | INJECTION | ₹8,919.00 |
Written by: SastiMedic Medical Team
Reviewed by: Registered Pharmacist